Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced that its focal Pulsed Field (PF) ablation technology, also known as Irreversible Electroporation (IRE), has been...
Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced that its focal Pulsed Field (PF) ablation technology, also known as Irreversible Electroporation (IRE), has been...
Affera, Inc., a private medical...